BackProteome Sciences plc Overview
Proteome Sciences plc

Proteome Sciences plc Return on Equity

Valuation check: PMSNF's ROE is 57.06%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

57.06%

Return on Equity

57.06%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Proteome Sciences plc (PMSNF) FAQ

The latest ROE for PMSNF is 57.06%. That is above the sector sector average of 11.3%. Investors often review this figure alongside Proteome Sciences plc's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PMSNF currently prints 57.06% for ROE, while the sector average sits near 11.3%. That is roughly 405.2% above the sector mean. Large gaps often invite a closer look at Proteome Sciences plc's growth, margins, and balance sheet.

Return on Equity shows how effectively Proteome Sciences plc converts resources into returns. At 57.06%, PMSNF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PMSNF's ROE (57.06%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.